2 withdrawn, 1 active not recruiting, 1 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 2 | Active not recruiting 1, Withdrawn 1 |
Follow JK07: new trials by email Literature Review of JK07 trials Research Report on JK07
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension JK07 - HFrEF - Heart Failure With Reduced Ejection Fraction, HFpEF - Heart Failure With Preserved Ejection Fraction | Phase 2 | Withdrawn | Salubris Biotherapeutics Inc | 2025-12-15 | 2026-05-15 | |
| Study of JK07 in Patients With Chronic Heart Failure JK07, Placebo - Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction | Phase 2 | Active not recruiting | Salubris Biotherapeutics Inc | 282 | 2024-03-28 | 2026-05-22 |
| Single-Ascending Dose Study of JK07 in Subjects With HFpEF JK07, Matching Placebo - Heart Failure With Preserved Ejection Fraction | Phase 1 | Withdrawn | Salubris Biotherapeutics Inc | 2022-10-21 | 2023-05-31 | |
| Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) JK07, Matching Placebo - Heart Failure With Reduced Ejection Fraction | Phase 1 | Completed | Salubris Biotherapeutics Inc | 14 | 2020-09-21 | 2025-07-09 |
Fibromatosis, Gingival, 2 (4) · Heart Failure (4) · Heart Failure, Diastolic (2) · Heart Failure, Systolic (2) · Atrial Fibrillation (1) · Atrial Flutter (1) · Hypertension, Pulmonary (1)
Salubris Biotherapeutics Inc (4)
United States (4) · Canada (1) · China (1) · Puerto Rico (1)
Wilson Tang, MD (2)